Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Journal of Immunology Research
|
May 12, 2015
IL-21: a pleiotropic cytokine with potential applications in oncology
Michela Croce, Valentina Rigo, Silvano Ferrini
Immunotherapy
|
March 26, 2015
New immunotherapeutic strategies for the treatment of neuroblastoma
Michela Croce, Maria Valeria Corrias, Valentina Rigo, et al.
Scientific Reports
|
October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
Valentina Rigo, Laura Emionite, Antonio Daga, et al.
Cancer Immunology, Immunotherapy : CII
|
March 21, 2014
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity
Valentina Rigo, Maria Valeria Corrias, Anna Maria Orengo, et al.
International Journal of Cancer
|
December 30, 2009
Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice
Michela Croce, Maria Valeria Corrias, Anna Maria Orengo, et al.
Journal of Immunology Research
|
May 12, 2015
IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome
Fabio Morandi, Michela Croce, Giuliana Cangemi, et al.
Frontiers in Immunology
|
January 21, 2026
Unveiling the myxofibrosarcoma tumor microenvironment: implications for immunotherapy
Cecilia Profumo, Massimiliano Grassi, Valentina Rigo, et al.
Oncotarget
|
September 30, 2016
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
Andrea Petretto, Grazia Carbotti, Elvira Inglese, et al.
Biomed Research International
|
July 11, 2015
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
Sara Stigliani, Michela Croce, Fabio Morandi, et al.
International Journal of Molecular Sciences
|
August 14, 2025
Assessing Determinants of Response to PARP Inhibition in Germline <i>ATM</i> Mutant Melanoma
Eleonora Allavena, Michela Croce, Bruna Dalmasso, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Journal of Immunology Research
|
May 12, 2015
IL-21: a pleiotropic cytokine with potential applications in oncology
Michela Croce, Valentina Rigo, Silvano Ferrini
Immunotherapy
|
March 26, 2015
New immunotherapeutic strategies for the treatment of neuroblastoma
Michela Croce, Maria Valeria Corrias, Valentina Rigo, et al.
Scientific Reports
|
October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
Valentina Rigo, Laura Emionite, Antonio Daga, et al.
Cancer Immunology, Immunotherapy : CII
|
March 21, 2014
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity
Valentina Rigo, Maria Valeria Corrias, Anna Maria Orengo, et al.
International Journal of Cancer
|
December 30, 2009
Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic mice
Michela Croce, Maria Valeria Corrias, Anna Maria Orengo, et al.
Journal of Immunology Research
|
May 12, 2015
IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcome
Fabio Morandi, Michela Croce, Giuliana Cangemi, et al.
Frontiers in Immunology
|
January 21, 2026
Unveiling the myxofibrosarcoma tumor microenvironment: implications for immunotherapy
Cecilia Profumo, Massimiliano Grassi, Valentina Rigo, et al.
Oncotarget
|
September 30, 2016
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
Andrea Petretto, Grazia Carbotti, Elvira Inglese, et al.
Biomed Research International
|
July 11, 2015
Expression of FOXP3, CD14, and ARG1 in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
Sara Stigliani, Michela Croce, Fabio Morandi, et al.
International Journal of Molecular Sciences
|
August 14, 2025
Assessing Determinants of Response to PARP Inhibition in Germline <i>ATM</i> Mutant Melanoma
Eleonora Allavena, Michela Croce, Bruna Dalmasso, et al.
Page
of 2